Fidelis Capital Partners’s Columbia Research Enhanced Core ETF RECS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$3.53M Buy
81,616
+8,402
+11% +$356K 0.2% 92
2026
Q1
$2.85M Buy
73,214
+8,899
+14% +$361K 0.2% 95
2025
Q4
$2.63M Buy
64,315
+13,256
+26% +$539K 0.19% 97
2025
Q3
$2.06M Buy
51,059
+1,116
+2% +$43K 0.16% 107
2025
Q2
$1.9M Buy
+49,943
New +$1.69M 0.17% 104

Other funds holding RECS

Fidelis Capital Partners's RECS Position: Q2 2026 in Review

Fidelis Capital Partners increased its Columbia Research Enhanced Core ETF (RECS) stake by 11% in Q2 2026, buying an estimated $356K and bringing the position to 81,616 shares worth $3.53M. The position accounts for 0.2% of the portfolio, ranked #92.

Fidelis Capital Partners first reported a position in RECS in Q2 2025 and has held it in 5 quarters since. 186 funds tracked by Wall St. Rank hold RECS as of Q2 2026.

  • Fidelis Capital Partners held 81,616 shares of Columbia Research Enhanced Core ETF worth $3.53M as of Q2 2026.
  • Fidelis Capital Partners bought 8,402 Columbia Research Enhanced Core ETF shares in Q2 2026, an estimated $356K.
  • Columbia Research Enhanced Core ETF made up 0.2% of Fidelis Capital Partners's portfolio in Q2 2026, its #92 holding.
  • Fidelis Capital Partners first reported a position in Columbia Research Enhanced Core ETF in Q2 2025 and has held it in 5 quarters since.
  • 186 funds tracked by Wall St. Rank held Columbia Research Enhanced Core ETF as of Q2 2026.

Based on Fidelis Capital Partners's 13F filing for Q2 2026, filed 13 Aug 2026.